Company: FENC
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001558370-25-003710
Chunk: 3

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 15
Chunk 3
---
Item 15.      Exhibits and Financial Statement Schedules

(a)The following documents are included as part of this Annual Report:

1.Financial Statements – See Index to Financial Statements on page F-1.

2.All schedules are omitted as the information required is inapplicable or the information is presented in the financial statements.

3.Exhibits:

​​ExhibitNo.    Description    Location     3.1 Notice of Articles dated August 25, 2011 Exhibit 3.2I to the Form 8-K of the Company filed August 26, 2011     3.2 Articles dated August 25, 2011 Exhibit 3.2II to the Form 8-K of the Company filed August 26, 2011     3.3 Notice of Alteration Dated September 3, 2014 Exhibit 3.1 to the Form 8-K of the Company filed September 9, 2014     4.1​Fennec Pharmaceuticals, Inc. Description of the Registrant’s Securities​Exhibit 4.1 to the Form 10-K of the Company filed March 29, 2024​​​​​10.1 Fennec Pharmaceuticals, Inc. 2020 Equity Incentive Plan* Schedule B to the Management Proxy Circular of the Company filed May 11, 2020     10.2 Executive Employment Agreement dated May 3, 2010 by and between Fennec Pharmaceuticals Inc. and Rostislav Raykov* Exhibit 10.28 to the Form 10-Q of the Company filed May 14, 2010     10.3 Form of Independent Director Agreement, dated May 3, 2010 Exhibit 10.31 to the Form 10-Q of the Company filed May 14, 2010     10.4 Executive Employment Agreement dated November 12, 2015 by and between Fennec Pharmaceuticals Inc. and Robert Andrade* Exhibit 10.40 to the Form 10-Q of the Company filed November 12, 2015     10.5 Form of Stock Option Award Agreement under 2020 Equity Incentive Plan* Filed herewith     10.6 Form of Restricted Stock Award Agreement under 2020 Equity Incentive Plan* Filed herewith​​​​